Clinical trials
Enrolling by invitation Observational Colorectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2019 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| A2 Biotherapeutics Inc. | 1 |
| Acibadem University | 1 |
| Dong Peng | 1 |
| Endeavor Health | 1 |
| Eva Haglind, MD, PhD, professor | 1 |
| Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental | 1 |
| Indiana University | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| Ma Yanlei | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Postoperative Complications | 2 |
| Anastomotic Leak | 1 |
| Anemia, Iron-Deficiency | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Diabetes Mellitus | 1 |
| Disease | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.